ERBB2 and breast cancer: Various formulationsfor LAP delivery have also been developed,including polymer–lipid hybrid nanoparticles, lyophilized polymericmicelles, exosomes, and gold nanorods, each demonstrating promisinganticancer effects in HER2-positive breast cancer models.